Martin Preisig

Prof. Dr. Martin Preisig

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
HWH.U. Wittchen
H.U. Wittchen
FJF. Jacobi
F. Jacobi
JRJ. Rehm
J. Rehm
AGA. Gustavsson
A. Gustavsson
MSMikael Svensson
Mikael Svensson
HSH.-C. Steinhausen
H.-C. Steinhausen

26 April 2018 in Nature Genetics
Verified
Journal Article
Open access
PDF file
NWNaomi R. Wray
Naomi R. Wray
SRStephan Ripke
Stephan Ripke
MMManuel Mattheisen
Manuel Mattheisen
MTMaciej Trzaskowski
Maciej Trzaskowski
EBEnda M. Byrne
Enda M. Byrne
EQEqtlgen
Eqtlgen
Major depressive disorder (MDD) is a common illness accompanied by considerable morbidity, mortality, costs, and heightened risk of suicide. We conducted a genome-wide association meta-analysis based in 135,458 cases and 344,901 controls and identified 44 independent and significant loci. The genetic findings were associated with clinical features of major depression and implicated brain regions exhibiting anatomical differences in cases. Targets of antidepressant medications and genes involved in gene splicing were enriched for smaller association signal. We found important relationships of genetic risk for major depression with educational attainment, body mass, and schizophrenia: lower educational attainment and higher body mass were putatively causal, whereas major depression and schizophrenia reflected a partly shared biological etiology. All humans carry lesser or greater numbers of genetic risk factors for major depression. These findings help refine the basis of major depression and imply that a continuous measure of risk underlies the clinical phenotype.

1 April 2015 in The Lancet Respiratory Medicine
Verified
Journal Article
Closed access
RHRaphael Heinzer
Raphael Heinzer
SVS Vat
S Vat
Pedro Marques-VidalPedro Marques-Vidal
Pedro Marques-Vidal
HMH Marti-Soler
H Marti-Soler
DAD Andries
D Andries
Jose Haba-RubioJose Haba-Rubio
Jose Haba-Rubio

1 December 2019 in Cell
Verified
Journal Article
Closed access
PLPhil H. Lee
Phil H. Lee
VAVerneri Anttila
Verneri Anttila
HWHyejung Won
Hyejung Won
YFYen-Chen A. Feng
Yen-Chen A. Feng
JRJacob Rosenthal
Jacob Rosenthal
JSJordan Smoller
Jordan Smoller

1 October 2011 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
AGAnders Gustavsson
Anders Gustavsson
MSMikael Svensson
Mikael Svensson
FJFrank Jacobi
Frank Jacobi
CAChrister Allgulander
Christer Allgulander
JAJordi Alonso
Jordi Alonso
NONiels Jørgen Olesen
Niels Jørgen Olesen

1 March 2017 in The Lancet
Verified
Journal Article
Open access
VRViviane Richard
Viviane Richard
CCCristian Carmeli
Cristian Carmeli
MJMarkus Jokela
Markus Jokela
PMPeter Muennig
Peter Muennig
FGFlorence Guida
Florence Guida
RTRosario Tumino
Rosario Tumino
In 2011, WHO member states signed up to the 25 × 25 initiative, a plan to cut mortality due to non-communicable diseases by 25% by 2025. However, socioeconomic factors influencing non-communicable diseases have not been included in the plan. In this study, we aimed to compare the contribution of socioeconomic status to mortality and years-of-life-lost with that of the 25 × 25 conventional risk factors. We did a multicohort study and meta-analysis with individual-level data from 48 independent prospective cohort studies with information about socioeconomic status, indexed by occupational position, 25 × 25 risk factors (high alcohol intake, physical inactivity, current smoking, hypertension, diabetes, and obesity), and mortality, for a total population of 1 751 479 (54% women) from seven high-income WHO member countries. We estimated the association of socioeconomic status and the 25 × 25 risk factors with all-cause mortality and cause-specific mortality by calculating minimally adjusted and mutually adjusted hazard ratios [HR] and 95% CIs. We also estimated the population attributable fraction and the years of life lost due to suboptimal risk factors. During 26·6 million person-years at risk (mean follow-up 13·3 years [SD 6·4 years]), 310 277 participants died. HR for the 25 × 25 risk factors and mortality varied between 1·04 (95% CI 0·98-1·11) for obesity in men and 2 ·17 (2·06-2·29) for current smoking in men. Participants with low socioeconomic status had greater mortality compared with those with high socioeconomic status (HR 1·42, 95% CI 1·38-1·45 for men; 1·34, 1·28-1·39 for women); this association remained significant in mutually adjusted models that included the 25 × 25 factors (HR 1·26, 1·21-1·32, men and women combined). The population attributable fraction was highest for smoking, followed by physical inactivity then socioeconomic status. Low socioeconomic status was associated with a 2·1-year reduction in life expectancy between ages 40 and 85 years, the corresponding years-of-life-lost were 0·5 years for high alcohol intake, 0·7 years for obesity, 3·9 years for diabetes, 1·6 years for hypertension, 2·4 years for physical inactivity, and 4·8 years for current smoking. Socioeconomic circumstances, in addition to the 25 × 25 factors, should be targeted by local and global health strategies and health risk surveillance to reduce mortality. European Commission, Swiss State Secretariat for Education, Swiss National Science Foundation, the Medical Research Council, NordForsk, Portuguese Foundation for Science and Technology.